急性脑梗死因发病率、致残率和致死率高,已经成为我国国民第一位的死亡原因,为中国疾病负担的首位[1],正以每年8.7%的速率上升,严重危害着人民群众的生命健康,给患者及其家庭和社会带来沉重的负担。其中缺血性脑卒中占70%~80%[2],近年来,国内外普遍开展了溶栓治疗急性脑梗死的临床研究,许多结果表明,早期溶栓是治疗脑梗死最有效、最有希望的方法。2010年中国急性缺血性脑卒中诊疗指南虽然已经将其列为1类证据、A级推 Acute cerebral infarction has become the leading cause of death in China due to its morbidity, morbidity and mortality. As the first cause of disease burden in China [1], it is rising at a rate of 8.7% per annum, seriously endangering the masses Life and health, to patients and their families and society a heavy burden. Including ischemic stroke accounted for 70% to 80% [2], in recent years, the general study of thrombolytic therapy of acute cerebral infarction in clinical trials, many of the results show that early thrombolytic therapy is the most effective treatment of cerebral infarction, the most Ways to hope. Although the Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke in China in 2010 have been classified as Class 1 evidence, Class A push